While it has been shown that activation of CXCR7, the receptor for CXCL11, using a synthetic ligand was able to reduce atherosclerosis in mice64, it is not known if CXCL11 binding to CXCR7 will result in the same response. This evidence concerns the gene CXCL11 and atherosclerosis.